SmithKline Beecham: Clinical Trials

8 trials sponsored by SmithKline Beecham, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 8 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 7, Unknown 1
Phase 11Completed 1

Follow SmithKline Beecham: new trials by email

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
Topotecan, Cyclophosphamide, Melphalan - Myeloma
Phase 2CompletedM.D. Anderson Cancer Center602002-02-182018-11-07
An Evaluation of Weekly Tafenoquine
Tafenoquine, Mefloquine, Placebo - Falciparum Parasitaemia
Phase 2CompletedU.S. Army Medical Research and Development Command3062000-05-012017-05-30
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
Cytarabine, Daunorubicin, Etoposide - Leukemia
Phase 1 / Phase 2CompletedH. Lee Moffitt Cancer Center and Research Institute411999-07-012012-09-25
A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum
Placebo, Tafenoquine 25mg, Tafenoquine 50mg - Malaria
Phase 2CompletedU.S. Army Medical Research and Development Command5211998-08-012018-09-13
Use of Topotecan in Patients With Refractory Acute Leukemia
Topotecan, Mitozantrone, Etoposide - Non-Hodgkin's Lymphoma, Leukemia
Phase 2CompletedUS Department of Veterans Affairs101998-08-012013-09-25
Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
carboplatin, paclitaxel, topotecan hydrochloride - Ovarian Cancer
Phase 2UnknownSmithKline Beecham401997-12-012013-09-20
Evaluation of Weekly Tafenoquine
Tafenoquine, Placebo - Malaria
Phase 2CompletedU.S. Army Medical Research and Development Command2491997-05-012018-09-13
Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
Topotecan - HIV Infections, Leukoencephalopathy, Progressive Multifocal
Phase 2CompletedSmithKline Beecham542005-06-24

Conditions studied

Malaria (3)  ·  Leukemia (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Congenital Abnormalities (1)  ·  HIV Infections (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Leukoencephalopathy, Progressive Multifocal (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)

Interventions

Topotecan (5)  ·  tafenoquine (3)  ·  Etoposide (2)  ·  Mefloquine (2)  ·  Carboplatin (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Daunorubicin (1)  ·  Melphalan (1)  ·  Mitoxantrone (1)  ·  Paclitaxel (1)

Countries

United States (4)  ·  United Kingdom (1)

Top investigators

A.J Oloo (1)  ·  Braden Hale, MD (1)  ·  Gordon J.S. Rustin, MD (1)  ·  Hussain I. Saba, MD, PhD (1)  ·  Jose Stoute, MD (1)  ·  Mark Mainwaring (1)  ·  Michelle Donato, MD (1)

Results publications

PMID 28495354, PMID 14970858